Translational Neuroendocrinology

Faculty of Medicine | Lund University

Welcome to the Translational Neuroendocrine Research Unit

The Translational Neuroendocrine Research Unit (TNU) was formed in 2007.

The research group focuses on the neuropsychiatric Huntington’s disease, and studies molecular mechanisms in the interface to depression, dementia and obesity.

Huntington’s disease (HD) is a fatal neurodegenerative hereditary CAG triplet repeat disorder without a cure. It is clinically characterized by anxiety, depression, metabolic disturbances, chorea and dementia. Neuropathological changes include neuronal dysfunction, protein aggregates and cell death in the cerebral cortex, the striatum and the hypothalamus.

The pathogenic process in HD and the relationships between regional changes and the behavioral consequences are not known. As it is a monogenetic disorder, experimental models of the disease may provide useful tools to elucidate molecular mechanisms underlying psychiatric symptoms. Emerging studies suggest that neuroendocrine and hypothalamic changes in HD may 1) cause symptoms and signs such as anxiety, depression and metabolic disturbances, 2) provide biomarkers to track disease progression and severity, and 3) be involved in the pathogenic disease process.

Studies addressing these points using experimental models and material from patients with HD are ongoing in the research group. Techniques used in the laboratory include detailed testing of motor, cognitive, depressive-and anxiety-like behaviours, stereotactic surgery, gene targeting and disease modeling using adeno-associated viral vectors (AAV), immunohistochemistry, stereology, ELISA, RIA, Western blots, HPLC, RT-PCR as well as MRI analysis.


Åsa Petersén lectures about psychiatric symptoms and research in HD  at the National Huntington Meeting in March 2014

Tour of our lab made by HDYO (Huntington's Disease Youth Organization) in May 2013:

Åsa Petersén lectures about HD and the hypothalamic studies in TNU for the general public at the Research Day in Nov 2010:

Åsa Petersén lectures about HD and the hypothalamic studies in TNU at the National Huntington Meeting in March 2013:

tnu at ehdn 2012
PhD students, postdoctoral fellows and group leader Petersén at the European HD Network conference in Stockholm 2012.

Contact

Åsa Petersén, MD, PhD 
Translational Neuroendocrinology (TNU), BMC D11
Lund University
221 84 Lund, Sweden
Phone: +46 46 222 16 86
Fax: +46 46 222 34 36
E-mail: Asa.Petersen@med.lu.se 

bmc d11

 

Relevant links 

Site overview